Molecular Profiling and Relationship with Clinical Response in Patients with IDH1 Mutation-Positive Hematologic Malignancies Receiving AG-120, a First-in-Class Potent Inhibitor of Mutant IDH1, in Addition to Data from the Completed Dose Escalation Portion of the Phase 1 Study
| Autor: | DiNardo, Courtney, de Botton, Stéphane *, Pollyea, Daniel A *, Stein, Eytan M, Fathi, Amir T., Roboz, Gail J, Collins, Robert, Swords, Ronan T., Flinn, Ian W., Altman, Jessica K *, Tallman, Martin S, Kantarjian, Hagop M., Derti, Adnan *, Goldwasser, Meredith *, Prahl, Malia *, Wu, Bin *, Yen, Katharine *, Agresta, Sam, Stone, Richard M. |
|---|---|
| Zdroj: | In Blood 3 December 2015 126(23):1306-1306 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|